Add to ORKGEffects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up stud
Peritoneal equilibration test with conventional ‘low pH/high glucose degradation product ’ or with b...
Peritoneal equilibration test with conventional ‘low pH/high glucose degradation product ’ or with b...
BACKGROUND: The benefits of biocompatible peritoneal dialysis (PD) fluids, particularly for residual...
Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on sy...
BACKGROUND: The local peritoneal effects of low-glucose degradation product (GDP)-containing periton...
Background Previous studies report conflicting results on the benefit of peritoneal dialysis (PD) pa...
Item does not contain fulltextBACKGROUND: During peritoneal dialysis (PD), solute transport and ultr...
¤ Background: Long-term peritoneal dialysis (PD) is asso-ciated with the development of various stru...
Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation...
Background. Long-term peritoneal dialysis (PD) is associated with the development of functional and ...
BACKGROUND: The balANZ trial recently reported that neutral pH, low glucose degradation product (bio...
Background. In vitro studies of peritoneal dialysis (PD) solutions demonstrated that a biocompatible...
effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume statu
♦ Background: The use of pH-neutral peritoneal dialysis (PD) fluids low in glucose degradation produ...
Abstract Supplement of JASN is located at http://www.asn-online.org/education/kidneyweek/archives/Di...
Peritoneal equilibration test with conventional ‘low pH/high glucose degradation product ’ or with b...
Peritoneal equilibration test with conventional ‘low pH/high glucose degradation product ’ or with b...
BACKGROUND: The benefits of biocompatible peritoneal dialysis (PD) fluids, particularly for residual...
Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on sy...
BACKGROUND: The local peritoneal effects of low-glucose degradation product (GDP)-containing periton...
Background Previous studies report conflicting results on the benefit of peritoneal dialysis (PD) pa...
Item does not contain fulltextBACKGROUND: During peritoneal dialysis (PD), solute transport and ultr...
¤ Background: Long-term peritoneal dialysis (PD) is asso-ciated with the development of various stru...
Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation...
Background. Long-term peritoneal dialysis (PD) is associated with the development of functional and ...
BACKGROUND: The balANZ trial recently reported that neutral pH, low glucose degradation product (bio...
Background. In vitro studies of peritoneal dialysis (PD) solutions demonstrated that a biocompatible...
effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume statu
♦ Background: The use of pH-neutral peritoneal dialysis (PD) fluids low in glucose degradation produ...
Abstract Supplement of JASN is located at http://www.asn-online.org/education/kidneyweek/archives/Di...
Peritoneal equilibration test with conventional ‘low pH/high glucose degradation product ’ or with b...
Peritoneal equilibration test with conventional ‘low pH/high glucose degradation product ’ or with b...
BACKGROUND: The benefits of biocompatible peritoneal dialysis (PD) fluids, particularly for residual...